Integrating large language models for improved failure mode and effects analysis (FMEA): a framework and case study
Proceedings of the Design Society · 2024-05 · 4 · 2019-2028
DOI: 10.1017/pds.2024.204 ↗Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the Design Society, online erschienen am 16.05.2024. Verfasst von Ibtissam El Hassani und 4 weiteren Autor:innen. Die Arbeit wurde bisher 33-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
The manual execution of failure mode and effects analysis (FMEA) is time-consuming and error-prone. This article presents an approach in which large language models (LLMs) are integrated into FMEA. LLMs improve and accelerate FMEA with human in the loop. The discussion looks at software tools for FMEA and emphasizes that the tools must be tailored to the needs of the company. Our framework combines data collection, pre-processing and reliability assessment to automate FMEA. A case study validates this framework and demonstrates its efficiency and accuracy compared to manual FMEA.
Zitieren
APA
Hassani, I. E., Masrour, T., Kourouma, N., Motte, D., & Tavčar, J. (2024). Integrating large language models for improved failure mode and effects analysis (FMEA): a framework and case study. Proceedings of the Design Society, 4, 2019-2028. https://doi.org/10.1017/pds.2024.204
Vancouver
Hassani IE, Masrour T, Kourouma N, Motte D, Tavčar J. Integrating large language models for improved failure mode and effects analysis (FMEA): a framework and case study. Proceedings of the Design Society. 2024;4:2019-2028. doi:10.1017/pds.2024.204
BibTeX
@article{Hassani2024,
author = {Hassani, Ibtissam El and Masrour, Tawfik and Kourouma, Nouhan and Motte, Damien and Tavčar, Jože},
title = {Integrating large language models for improved failure mode and effects analysis (FMEA): a framework and case study},
journal = {Proceedings of the Design Society},
year = {2024},
volume = {4},
pages = {2019--2028},
doi = {10.1017/pds.2024.204}
}
EUVIMED